Long-term results of a phase I/II study of high-dose thoracic radiotherapy with concomitant cisplatin and etoposide in limited stage small-cell lung cancer.

Brown, P D; Bonner, J A; Foote, R L; Frytak, S; Marks, R S; Richardson, R L; Creagan, E T

Brown, P D; Bonner, J A; Foote, R L; Frytak, S; Marks, R S; Richardson, R L; Creagan, E T.

Affiliation

Brown PD; Division of Radiation Oncology, Mayo Clinic, Rochester, Minnesota 55905, USA.

Am J Clin Oncol ; 24(6): 556-61, 2001 Dec.

Article in En | MEDLINE | ID: mdl-11801753

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Carcinoma, Small Cell/drug therapy; Carcinoma, Small Cell/radiotherapy; Lung Neoplasms/drug therapy; Lung Neoplasms/radiotherapy; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Brain Neoplasms/prevention & control; Brain Neoplasms/secondary; Carcinoma, Small Cell/secondary; Cisplatin/administration & dosage; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide/administration & dosage; Disease-Free Survival; Dose Fractionation, Radiation; Etoposide/administration & dosage; Female; Humans; Lung Neoplasms/pathology; Male; Middle Aged

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Small Cell / Lung Neoplasms Type of study: Guideline Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Am J Clin Oncol Year: 2001 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links